Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
NexgenRx ( (TSE:NXG) ) just unveiled an announcement.
NexgenRx reported significant financial growth in the third quarter of 2025, with revenue increasing by 13.43% to $4,616,066 and EBITDA rising to $887,671. This growth is attributed to organic expansion of existing clients and effective cost control measures, despite increased operating expenses. The company’s strong recurring revenues and sales pipelines have positioned it to continue generating free cash flow, enhancing shareholder value.
More about NexgenRx
NexgenRx is Canada’s only independent full-service Third-Party Administrator and Technology Solutions Provider. The company offers proprietary full front-end, eligibility, enrolment, hour bank, and mobile access capabilities, along with state-of-the-art claims adjudication and full provider network coverage. NexgenRx operates in a cost-effective SaaS model, providing sophisticated administration and health benefit technology applications to Plan Sponsors.
Average Trading Volume: 16,154
Technical Sentiment Signal: Buy
Current Market Cap: C$30.58M
Learn more about NXG stock on TipRanks’ Stock Analysis page.